three code breaking events occurred, one due to mild but multiple adverse events (AE) and two due to serious adverse events (SAE)
Recommended Frequency As occasionally desired, 1x / month, 1x / week, or as often as 2-3x / week To treat symptoms of chronic conditions: 2-3x / week for 6+ weeks, then maintain well-being with an infusion 1x / week or 2-3x / month *Discuss goals and conditions with your provider These statements have not been evaluated by the FDA
Protecting the integrity of these delicate molecules is paramount, and its a responsibility we take very seriously, both in our own labs and in supporting yours
How LC-MS Supports Peptide Identity Review LC-MS supports peptide identity review by combining liquid chromatography with mass spectrometry data
Mitochondria-derived peptides in aging and healthspan
The cadence depends on your goals and how you feel